HPL Pharmaceuticals: Major
Health Technology
Mkt Cap
38.7B
P/E (TTM)
12.64
EPS
300.69
ROE
37.58%
Div Yield
5.99%
5 years
FY2025FY2024FY2023FY2022FY2021
Profitability
Return on Equity (ROE)38.65%30.23%6.87%3.25%18.53%
Return on Assets (ROA)20.59%15.73%3.23%1.54%10.06%
Return on Invested Capital37.60%29.72%6.87%3.24%18.15%
Gross Margin36.55%30.38%25.11%25.49%24.77%
Operating Margin18.41%11.41%8.11%6.34%8.80%
EBITDA Margin19.56%12.56%9.58%7.88%10.92%
Net Margin9.37%6.94%1.69%0.90%5.70%
Pre-Tax Margin16.00%11.78%3.42%3.90%9.05%
Liquidity
Current Ratio1.711.681.781.411.83
Quick Ratio0.610.430.780.720.72
Leverage
Debt / Equity0.030.210.000.320.04
Debt / Assets0.020.100.000.130.02
LT Debt / Equity0.030.030.000.000.01
LT Debt / Assets0.010.020.000.000.00
Net Debt-1.18B409.46M-1.29B-930.68M-732.97M
Total Debt261.47M1.41B01.63B200.82M
Efficiency
Asset Turnover2.202.271.911.711.76
Inventory Turnover2.642.973.402.932.95
Per Share
Book Value Per Share706.60567.30521.49541.07
Tangible Book Per Share706.14565.94521.22540.78
Cash Per Share103.89134.22265.7896.82
Total Debt Per Share146.350.00169.2820.82
Working Capital Per Share460.14354.32309.46344.57
Shares & Market
Total Shares Outstanding9,644,7609,644,7609,644,7609,644,760
Market Cap27.01B11.57B9.24B8.66B
Enterprise Value27.41B10.28B8.31B7.92B
Employees837734744869
Shareholders1,0781,0781,0781,0781,078